Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
To obtain the most accurate pricing tailored to your individual needs, we encourage you to schedule a consultation
After obtaining favorable results in the investigator-initiated Phase III trial JETALS, and following consultation with Tokushima University, Eisai submitted a new drug application for the treatment of ALS in Japan in January 2024, leading to its approval in September, 2024 and leading to the launch today
Should I get help before starting a tirzepatide program
Step 2: Draw the Diluent Using a 3 mL syringe with a drawing needle, pull up 2 mL of bacteriostatic water
Additionally, bacteriostatic water provides consistency in terms of reconstituting peptide concentration before use
Warnings for Egrifta WR Included as part of the PRECAUTIONS section
US$ 26.33
US$ 22.96
US$ 29.03
US$ 29.65
US$ 26.29
US$ 24.51
US$ 24.88
